Co-Diagnostics has completed an assay development strategy for the Bundibugyo virus, the strain of Ebola responsible for a recent outbreak in the Democratic Republic of the Congo and Uganda that led the World Health Organization to declare a public health emergency of international concern on May 17, 2026. Co-Diagnostics has stated it is prepared to rapidly make the test available on its Co Dx PCR point of care platform should the need arise.
Additionally, the Co-Diagnostics platform's cloud-connected architecture also means that public health authorities could track cases in near real time, leading to more targeted containment measures — from localized travel advisories to hospital preparedness efforts.
Even for someone who never contracts Ebola, the same platform and assay development approach could be adapted for other pathogens.
Point-Of-Care Virus Testing
Co-Diagnostics Offers an Assay Development Strategy
Trend Themes
-
Rapid Point-of-care PCR — Decentralized PCR devices capable of delivering lab-grade results at the bedside could shorten diagnostic timelines and shift testing away from centralized laboratories.
-
Cloud-connected Disease Surveillance — Near real-time case reporting via cloud-linked diagnostics may enable fine-grained public health visibility and predictive outbreak modeling.
-
Modular Assay Development — A platform approach that allows rapid assay adaptation for new pathogens could compress vaccine and therapeutic trial timelines by enabling faster case identification.
Industry Implications
-
Public Health and Epidemiology — Integrated point-of-care testing with centralized data streams may transform outbreak response strategies and resource allocation at regional and national levels.
-
Travel and Transportation — Real-time diagnostic verification at transit hubs could redefine screening protocols and risk management for international travel networks.
-
Hospital and Clinical Preparedness — On-site rapid molecular diagnostics combined with predictive case data may reshape emergency department triage, isolation planning, and supply chain readiness.